Clinical Trials

Text Size A A

E-Mail to a Friend






secret  Click to Play Audio


Merkel Cell Carcinoma

 

Interleukin-12 by Electroporation for Merkel Cell Carcinoma
A Phase II Study of Intratumoral Injection of Interleukin-12 Plasmid and in Vivo Electroporation in Patients With Merkel Cell Carcinoma

Investigator: Shailender Bhatia, M.D.;   Conditions: Merkel Cell Carcinoma;    Status: Recruiting;   Study ID: NCT01440816

Viral Oncoprotein Targeted Autologous T Cell Therapy for Merkel Cell Carcinoma (2586)
Study to Evaluate Cellular Adoptive Immunotherapy Using Polyclonal Autologous CD8+ Antigen-Specific T Cells for Metastatic Merkel Cell Carcinoma

Investigator: Aude Chapuis, MD;   Conditions: Merkel Cell Carcinoma;    Status: Recruiting;   Study ID: NCT01758458

MSB0010718C for Metastatic Merkel Cell Carcinoma
A Phase II, Open-label, Multicenter Trial to Investigate the Clinical Activity and Safety of MSB0010718C in Subjects With Merkel Cell Carcinoma

Investigator: Shailender Bhatia, M.D.;   Conditions: Merkel Cell Carcinoma;    Status: Recruiting;   Study ID: NCT02155647

MK-3475 for Advanced Merkel Cell Carcinoma (8269a)
A Phase II Study of MK-3475 in Patients with Advanced Merkel Cell Carcinoma (MCC)

Investigator: Paul Nghiem;   Conditions: Recurrent Merkel Cell Carcinoma, Stage III Merkel Cell Carcinoma, Stage IV Merkel Cell Carcinoma;    Status: Recruiting;   Study ID: NCT02267603